SL
INDV icon

Salomon & Ludwin’s Indivior Pharmaceuticals INDV Stock Holding History

Salomon & Ludwin’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.4K Buy
1,028
+962
+1,458% +$34.9K ﹤0.01% 640
2026
Q1 		$2.01K Sell
66
-773
-92% -$25.5K ﹤0.01% 1932
2025
Q4 		$30.4K Buy
+839
New +$25.6K ﹤0.01% 604

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Salomon & Ludwin's INDV Position: Q2 2026 in Review

Salomon & Ludwin increased its Indivior Pharmaceuticals (INDV) stake by 1,458% in Q2 2026, buying an estimated $34.9K and bringing the position to 1,028 shares worth $41.4K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Salomon & Ludwin first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Salomon & Ludwin held 1,028 shares of Indivior Pharmaceuticals worth $41.4K as of Q2 2026.
  • Salomon & Ludwin bought 962 Indivior Pharmaceuticals shares in Q2 2026, an estimated $34.9K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #640 holding.
  • Salomon & Ludwin first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.